FDA Inspection 1067584 — Novartis Pharma AG
The FDA completed an inspection of Novartis Pharma AG on Aug 24, 2018 in Basel. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 24, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Basel (Switzerland)
Additional Details
Bioanalytical BA/BE